Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
Business Wire•21/10/2026•16:05 ET
0
Key Highlights
- ➤Acadia (ACAD) will report third-quarter 2026 financial results November 4, 2026
- ➤Management will host a conference call and webcast at 4:30 p.m. Eastern Time
- ➤Commercial portfolio includes FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome
- ➤Pipeline includes mid- to late-stage Alzheimer’s and Lewy body dementia psychosis programs
Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
Company to host conference call and webcast on Wednesday, November 4, 2026, at 4:30 p.m. Eastern Time
Get started
Create a free account to read the full story.